1. Home
  2. USB vs SYK Comparison

USB vs SYK Comparison

Compare USB & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U.S. Bancorp

USB

U.S. Bancorp

N/A

Current Price

$65.54

Market Cap

98.4B

Sector

Finance

ML Signal

N/A

Logo Stryker Corporation

SYK

Stryker Corporation

N/A

Current Price

$336.32

Market Cap

120.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
USB
SYK
Founded
1863
1941
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.4B
120.7B
IPO Year
2008
1994

Fundamental Metrics

Financial Performance
Metric
USB
SYK
Price
$65.54
$336.32
Analyst Decision
Buy
Buy
Analyst Count
19
14
Target Price
$60.28
$415.57
AVG Volume (30 Days)
6.7M
2.1M
Earning Date
04-16-2026
04-30-2026
Dividend Yield
3.70%
1.12%
EPS Growth
21.90
8.25
EPS
2.53
5.23
Revenue
$28,656,000,000.00
$25,116,000,000.00
Revenue This Year
$16.09
$9.80
Revenue Next Year
$5.36
$8.44
P/E Ratio
$25.86
$64.86
Revenue Growth
4.37
11.16
52 Week Low
$45.02
$281.00
52 Week High
$65.61
$396.86

Technical Indicators

Market Signals
Indicator
USB
SYK
Relative Strength Index (RSI) 66.34 50.78
Support Level $62.34 $321.72
Resistance Level N/A $335.45
Average True Range (ATR) 0.94 8.72
MACD 0.01 -0.80
Stochastic Oscillator 82.75 51.03

Price Performance

Historical Comparison
USB
SYK

About USB U.S. Bancorp

With assets of around $700 billion, U.S. Bancorp is one of the largest regional banks in the US with its footprint in 26 states. The bank's branch network is mostly in Midwestern and Western markets. U.S. Bancorp has a comprehensive product set, with offerings in retail and commercial banking, credit cards, mortgages, payment services, trust, wealth, and capital market services.

About SYK Stryker Corporation

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Share on Social Networks: